Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02930109
Title A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Prescient Therapeutics, Ltd.
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

chronic myeloid leukemia

Therapies

Cytarabine + Triciribine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.